KI-Beratung Beta

Gutscheinbedingungen

**Gültig bis 18.11.2026 auf englischsprachige Klassiker (klassiker-32728) online auf thalia.at und in der Thalia App. Einzelne Artikel können ausgeschlossen sein. Ausgenommen sind preisgebundene Artikel & eBooks. Pro Einkauf einmal einlösbar. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Geschenkkarten, Versandkosten und Services.

Produktbild: Protein Repair Mechanisms in Alzheimer's Disease
Vorbesteller Neu

Protein Repair Mechanisms in Alzheimer's Disease Molecular Pathways and Therapeutic Frontiers

214,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Protein Repair Mechanisms in Alzheimer’s Disease: Molecular Pathways and Therapeutic Frontiers offers a detailed examination of the molecular processes that maintain neuronal proteostasis and how their disruption contributes to Alzheimer’s disease progression. The book is structured into five sections,...

Beschreibung

Protein Repair Mechanisms in Alzheimer’s Disease: Molecular Pathways and Therapeutic Frontiers offers a detailed examination of the molecular processes that maintain neuronal proteostasis and how their disruption contributes to Alzheimer’s disease progression.
The book is structured into five sections, beginning with foundational concepts including protein quality control, age-related proteostasis decline, heat-shock response, chaperone networks, and endoplasmic reticulum stress. Focus then turns to the cellular mechanisms responsible for protein degradation and clearance, including the ubiquitin-proteasome system, autophagy-lysosome axis, mitochondrial quality control, and extracellular proteostasis. The book also explores key molecular modulators of protein repair, such as disaggregases, isomerases, kinases, and tau protein. It then considers cellular and systemic perspectives, highlighting the roles of glial cells and synaptic proteostasis in neurodegeneration. The final section examines translational insights and emerging therapeutic applications, including novel biomarkers, autophagy enhancers, proteolysis-targeting chimeras (PROTACs), and gene-editing techniques. Combination therapies and multi-omics approaches are also covered, with a look towards future possibilities and challenges that need to be tackled in translating these advances into clinical practice.
By addressing the complex interplay of protein repair systems and neurodegeneration, this reference delivers a mechanistic understanding of Alzheimer’s disease, bridging fundamental molecular science with translational medicine. It serves as an invaluable resource for researchers, students and clinicians seeking insights into how these mechanisms can be harnessed to develop targeted treatments that slow or mitigate neurodegenerative disease progression.

Portrait

Meenakshi Dhanawat is Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, India. Her research spans medicinal chemistry, synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction, with a particular focus on central nervous system drug delivery. She is a recipient of the Rajiv Gandhi National Fellowship.

Arun Kumar Singh is Assistant Professor in the Department of Pharmacy at the University School of Pharmaceutical Sciences, Rayat Bahra University, Sahauran, India. His research interests include nano-formulation, cancer biology, and neuroscience, alongside digital and computational approaches such as machine learning, artificial intelligence, big data analytics, blockchain, and the Internet of Things. He has contributed academic books, book chapters, and review articles in pharmaceutical sciences and healthcare technology, with a focus on interdisciplinary approaches that integrate pharmaceutical research with emerging digital technologies.

Garima Malik is Assistant Professor in the Department of Pharmaceutics at M.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana, Ambala, India. Her research focuses on nanotechnology, hydrogels, and biomaterials, and their application in drug delivery. She has contributed research articles, book chapters, and a patent, and previously worked in quality control in the pharmaceutical industry.

Dilip Sharma is a pharmacologist whose research spans neuroscience, molecular biology, and translational medicine. He is currently Assistant Professor in the Amity Institute of Pharmacy, India. Prior to this, he completed postdoctoral training in Anesthesiology at Rutgers New Jersey Medical School, where he developed rodent models of diabetic and chemotherapy-induced neuropathic pain. His earlier work investigated Rho-kinase-inhibitory GLP-1 secretagogues for diabetic nephropathy. He serves as a reviewer and editorial board member for several journals.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

30.03.2027

Herausgeber Meenakshi Dhanawat + weitere
Verlag Elsevier

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

30.03.2027

Herausgeber
Verlag Elsevier
Seitenzahl

360

Maße (L/B)

23,5/19,1 cm

Sprache

Englisch

ISBN

978-0-443-51636-8

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Weitere Artikel finden Sie in

  • Produktbild: Protein Repair Mechanisms in Alzheimer's Disease
  • Section I: Foundations of proteostasis in alzheimer’s disease
    1. Introduction to proteostasis and protein quality control, with age-related proteostasis collapse as a risk factor for AD
    2. Heat-shock response and chaperone networks
    3. Endoplasmic reticulum stress, unfolded protein response, and ER-associated degradation

    Section II: Protein degradation pathways and clearance systems
    4. The ubiquitin-proteasome system: mechanisms and failures in AD
    5. Autophagy-lysosome axis and selective aggrephagy
    6. Mitochondrial proteostasis and mitophagy in neuronal survival
    7. Extracellular proteostasis and aß clearance pathways

    Section III: Molecular modulators of protein repair
    8. Disaggregases, liquid-liquid phase separation, and tau/aß assembly states
    9. Chemical damage to proteins and enzymatic repair mechanisms
    10. Isomerases, kinases, and tau conformational control
    11. Fidelity at the ribosome: co-translational quality control and ribosome-associated quality control (RQC)

    Section IV: Cellular and systemic perspectives
    12. Glial proteostasis and neuroinflammation crosstalk
    13. Synaptic proteome turnover and local translation control

    Section V: Translational insights and therapeutic horizons
    14. Multi-omics mapping and mechanistic biomarkers of proteostasis in AD
    15. Therapeutic repair strategies: chaperone inducers, autophagy enhancers, proteolysis-targeting drugs and amyloid immunotherapy
    16. Clinical translation, combination therapies, and future frontiers